Mistakes, misunderstandings and controversies in diabetes: A review and personal account.
A number of controversies in diabetes have had too little attention. I discuss the following issues: (i) drug therapy; (ii) genetics; (iii) antihypertensive treatment in patients with normoalbuminuria and with abnormal albuminuria; (iv) insulin analogs; (v) cancer in diabetes; (vi) hypophysectomy; (vii) renal biopsy; (viii) low protein diet; and (ix) glycated hemoglobin. A closer look at these items is required in order to have a more realistic picture of diabetes research. A scheme of other controversies is also provided. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00012.x, 2010).
Medical Department M, Aarhus Sygehus and University of Aarhus, Aarhus, Denmark.
Carl Erik
CE
Mogensen
Drug and dietary therapy; Glycated hemoglobin; Glycemic control